News

CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.

Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.

MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.

FDA releases guidance on developing drugs for the treatment of community-acquired bacterial pneumonia.

Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.

FDA releases guidance on the qualification of drug development tools.

Zymeworks has entered into a licensing and collaboration agreement with ImClone Systems to develop novel bi-specific antibody oncology therapeutics.

GE acquires Thermo Fisher-s HyClone cell culture media and sera products, gene modulation technologies, and magnetic beads businesses.

Abrams Royal Pharmacy is recalling all unexpired lots of sterile products dispensed in the US.

Baxter International recalls dextrose injection and four sodium chloride injections.

Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

CMC Biologics and OnoSynergy form an agreement from cell-line development.

Pfizer appoints management changes to take effect in 2014.

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.

ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.

FDA and EMA launch initiative to share bioequivalence inspection information.

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.

AstraZeneca issues a statement regarding the launch of esomeprazole strontium in the United States.

AstraZeneca's MedImmune will collaborate with Johns Hopkins University in both biologics and small-molecule projects.

Merck's new facility for aseptic production in Reinbek, Germany is scheduled to be completed in 2016.

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

Agency issues precautionary recall due to manufacturing fault.

Agency issues precautionary recall due to manufacturing fault.

FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.

Johnson&Johnson will open a network of partnering offices across the UK.